医薬品インタビューフォーム
Contents
1.2. IF IF KN 7
3. TF IF A 4 IF E IF 2 IF TIF 9 9
4. 7 1 2
5. 5 Ta Xa 2 3 4 ACT APTT 2 A l 20 mL
6. 1 2mg I NS bi 14 1 2 3 3 5
7. 2 3 1 1 2 3 4 5 6 2 1 2 3 4 5 6 7 3 1 2 3 4
8. 2 3 Ss AST GOT ALT GPT A1 P ipm 5
9. 3 t PA 8 1 2 1 HIT HIT
10. 3 4 5 amp 3 6 7 SS 8 9 10
11. 9 10 2010 1 5 100 mL 22200AMX00001 150 mL 22200AMX00003 200 mL 22200AMX00002 11 2010 5 28 2010 5 28 12 13 14 15 16 HOT 100 mL 119892801 3334404G4020 621989201 150 mL 119893501 3334404G5026 621989301 200 mL 119894201 3334404G6022 621989401 17
12. 3 HIT heparin induced thrombocytopenia HIT VM 15 3 3 4 5 6 1 2
13. 3 E IF IF 2008 PDF H MR os IF MR IF 21 4 IF 2008 M Rs I 7 IF
14. 1 2 WI 14 5 6 100 mL 2 000 20mL 20mL 10 30 150 mL 3 000 20mL 20mL 10 30 200 mL 4 000 20mL 20mL 10 30 7 00 wr 100 mL 20mL 150 mL 20mL 200 mL 20mL 500 mL 10mL ILS
15. 2 1 1 amp ATTT 2 9 AT AT X Xa Ta Xa Ia Xa
16. 15 2 1 Xa Ct 2 3 HIT 4 HIT II HIT 100 HIT WI 2 3
17. a i H 3 63 10 2 IF IF 3 IF IF E
18. 6 VI 8 3 10 1 2 11 0 12
19. 16 1 1 V 2 3 4 2 1 3 4 1 2 3 4 XX m 1 amp 2
20. Ta APTT Andersson Xa Ia Xa 100 mL 150 mL 200 mL 20mL 100 150 200 mL 20mL 2010 1 1
21. 1 2 XI 1 100 150 200 mL 2 Andersson L 0 et al Thromb Res 9 575 1976 3 Weitz J I N Engl J Med 337 688 1997 4 Thomas D P and Merton R E Thromb Res 28 343 1982 5 ILS 6 Blajchman M A et al Ann N Y Acad Sci 556 245 1989 XI 1 2 A sl 1 Ya ra
22. 6 WI 4 11 IV 6 GR RE RNR ts 6 1 FC 11 IV 7 7 11 IV 8 ET FFP 7 3 2 1 1 IV 9 7 4 NE EN NY 11 A 7 5 11 IV 11 RR ER RR RE en 4 VI 5 PR RE NS RR 12 IV 12 7 12 2 CYP450 12
23. 12 3 12 5 12 VI 6 VR A NR RR WN RN 12 12 2 SN 12 3 Ee OE EE 12 VI 7 SYS GA 12 VI 13 1 HE 13 VWI 2 13 WI 3 VM 4 RC Re 13 VM 5 13 VI 6 13 7 14 1 1 14 2 1 RE RR CR EE 14 VM 8 15 1 NE ER EC RR RE RS RS 15 2 H EE CE Er 15 3 EN Rh RN RR RR RS 15 4 15 5 1 a ER RE 15 6 15 MI 9 RR TE EE 16 VWI 10 16 11 16 WI 12 16 VI 13 DB
24. 0 20mL 37 1 3 XX a 0 10mL 37 1C 30 0 20mL 37 1C 3 1 2 0 30mL 0 10mL pH8 4 0 70mL 0 10mL 0 10mL 0 20mL 0 30mL 1 2 0 30mL 405nm 3 TU
25. 9 MA IF 1I F E HI 1 E 4 IF IF 4 IF
26. 100 mL 20mL 40 1C 6 8 75 5 RH 25 2 37 60 59 6RH 150 mL 20mL 40 1 6 75 5 RH 25 2 7 AE 60 596RH 200 mL 20mL 40 1 6 75 5 RH 25 2 37 60 596RH
27. 11 1 11 IV 5 2 11 IV 1 5 3 11 1 0 hE Rt 5 PR RC 11 pH 11 pH 5 3 11 EE IEE A EC NE 5 VI 2 J 11 IV 2 RE CE NEN RR RI AEE 5 1 NE EE GS 11 1 5 2 EACCESS 11 2 el RR ER RN RRNA ER 5 3 ER RE EAA moe Te 11 3 ee 5 4 11 4 5 5 11 5 sc 5 6 GR RE RR nar PROC 11 IV 3 6 t 11 IV 4 6 VI 3 11 IV 5
28. 1 2 lt EE EE 3 4 gs
29. 5 5 1 2 CYP450 3 5 6 1 3 7 2 1 2 VI 10 1 2
30. IF H 2 7 I F 10 20 F 9 1 0
31. TIF IF H IF IF Pf 2008 IF 1 2008 PDF IF IE 6 2008
32. 1 XX T I 1 1 2 100 mL 20mL amp 150 mL 20mL amp 200 mL 20mL 2 MINIHEPA 100Units mL 150Units mL amp 200Units mL Syringe 20mL for Dialysis 3 MINI HEPA 2 1 Parnaparin Sodium 2 3 parin NN NN OD 7 AON A AOR oh OR
33. Parnaparin Sodium 2010 1 5 2010 5 28 2010 5 28 TEL06 6964 2763 FAX 06 6964 2706 9 00 lt 17 30 http www fuso pharm co jp IF 2010 5 http www info pmda go jp IF i H
34. 8 I 3 2 2 EE RE EE EE EER I EC RR 8 I 4 2 3 YR 8 I 5 2 4 8 II 6 i 2 6 9 T 7 CAS 2 1 9 HI 8 3 2 1 3 Sn EE A Ee ER 9 1 5 1 0 1 0 0 3 2 3 VI 10 3 3 VW 1 10 4 3 VI 2 10 5 3 1 10 6 3 2 10 7 3 3 10 2 3 3 0 3 VI 11 I 4 4 WI 1
35. 6 IV 7 10mL 0 1mo1 L NaOH 0 1mo1 L HC1 pH pH pH pH gt 100 mL 20mL pH 1 2 3 4 5 6 7 8 9 10 11 12 13 14 10 0 mL 10 0 mL 0 1mo1 L HC1 0 1mo1 L NaOH 1 36 5 86 pH 12 47 150 mL 20mL pH 1 2 3 4 5 6 7 8 9 10 11 12 13 14 10 0 mL 10 0 mL 0 1mo1 L HC1 0 1mo1 L NaOH 1 38 5 77 pH 12 38 200 mL 20mL pH 1 2 3 4 5 6 7 8 9 10 11 12 13 14 10 0 mL 10 0 mL 0 1mol L HC1 0 1mo1 L NaOH 1 38 5 73 pH 12 39 8 3 9 10 11 Xa
36. 12 13 X 4 14 V mb mk CC 1 1 1 7 13 kg 2 15 20 kg 6 8 kg 2
37. 3 000 Xa 200 mL 20mL 1 20mL 4 000 Xa 2 pH pH pH 5 0 7 0 1 0 1 1 3 2 1 IV 1 1 2 0 18 g 20mL pH pH 3 4 5 IV 3 4 5
38. X 9 21 X 10 21 XX 11 1 AO 0767 KGS 6 0 21 X 12 X 13 22 X 14 22 X 15 22 Xx 16 RR CRN RNR RRC UR 22 XX 17 oe 22 I RR ER SAR CERES A CER TR EC RE RC ER RT 23 xX 1 EA RE DE EE EE EE ts 23 X 2 SE 23 XI ER Ee 24 NI 1 NE RE EE RE Rt 24 2I 2 24 XM 2 SR RD Sp im 25 ER SAS meta 25 I McLean 1916 Xa Ta
39. 1 100000 10mL 1 20 1 0 01 g 50mL b 1mL 0 4 0 6 0 8 TU X a 2 0 10mL pH8 4 0 70mL 0 10mL 0 10mL
40. 2010 5 1 873334 IF 2008 100 ImL 20mL 150 I mL 20mL 200 InmL 20mL AINIHEPA 100 Units mL 150 Units mL amp 200 Units mL Syringe 20mL for Dialysis j 100 mL 20mL 1 20mL 2 000 lt Xa 150 mL 20mL 1 20mL 3 000 0 Xa 200 mL 20mL 20mL 4 000 Xa
41. HNR oR J HNR R SO3Na or Hi Rz SO3Na or COCHi R3 H R COONa or R COONa R H n 3 20 4 4 500 6 500 2 0 2 4 5 Du 6 7 CAS 1 1 0 2 95 3 4 5 6 7 0 01g 1mL pH 6 0 8 0 2 3 1 1 20 0 1mnL O
42. 1mg IU Ni 1mg TU 1mL IU Xx 50xb aXc a mg b 10mg 50mL c 100 100 IV 1 1 100 mL 20mL 1 20mL 2 000 Xa 150 mL 20mL 1 20mL
43. 10 15 kg 6 9 kg 2 3 1 2 3 1 lt 4 5 1 2 3 4 V 6 1 2 VI 1
44. 2008 9 I 1 IV 13 7 I 1 1 IV 14 4 1 2 1 V 8 II 2 V 1 8 IL 1 2 V 2 8 1 2 V 3 8 2 2 1 8 3 2 2 EE EC ES ts 8 I 2 2 3 8 1 2 8 2 2 5 8 3 2 1
45. SD RE ROLE DR 16 WI 14 RD ARC I AS TE GAR CN RS 17 VI 15 1 Pr 18 WM 16 18 19 TX 1 RE ER RR RR IRS 19 VI RR CRN RN RR RN PR 19 2 19 3 CE 19 4 RC FR 19 TX 2 OKA SC 19 1 19 2 670 0 NR CR RS 19 3 tt 19 4 NR SA RR 19 20 1 ROOT 20 X 2 20 X 3 20 X 4 20 1 20 AE EE RRR 20 X 5 PICO 21 xX 6 RC RE CE Ee TE et 21 XX 7 ER RE NR RI os 21 XxX 8 7 CE ar RO a
Download Pdf Manuals
Related Search